Epidemiology of Malaria in European Travelers

  • P. A. Phillips-Howard
  • D. J. Bradley


Malaria imposes an increasing risk to travelers, due primarily to the expansion of travel to highly endemic areas. Concomitantly, the spread of resistance to safe chemoprophylaxis and the diminished use of more efficacious drug combinations, because of toxicity, necessitates comprehensive and systematic appraisal of malaria risk [1]. In order to develop optimal recommendations to protect European travelers, we need to classify who is at risk and why.


Toxicity Europe Malaria Plasmodium Nigeria 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    WHO (1987) Bases for development of recommendations on protection for short term travelers against malaria. WHO/MAL/87.1040, GenevaGoogle Scholar
  2. 2.
    WHO (1987) Malaria risk for travelers. Report of a WHO working group. EUR/ ICP/MAL 012, GenevaGoogle Scholar
  3. 3.
    WHO (1977) Imported malaria in Europe. Weekly Epid Rec 52:89–90Google Scholar
  4. 4.
    Varnai F, Banhegyi D (1986) Experiences with malaria chemoprophylaxis. Ann Trop Med Parasitol 80:279–283PubMedGoogle Scholar
  5. 5.
    Phillips-Howard PA, Breeze E, Lakin C, Bradley DJ (1988) Short term travel to malarious areas: risk to UK residents. Travel Med Int: 6, 2, 51–60Google Scholar
  6. 6.
    WTO (1986) Yearbook of tourism statistics, vol I and II, 39th issue. World Tourism Organisation, MadridGoogle Scholar
  7. 7.
    Lobel HO, Roberts JM, Somaini B, Steffen R (1987) Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya. J Infect Dis 155:1205–1209PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • P. A. Phillips-Howard
  • D. J. Bradley

There are no affiliations available

Personalised recommendations